Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis

Objective: Cytomegalovirus (CMV) reactivation is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). Introduction of letermovir (LMV) seems to improve posttransplant outcomes, but delayed-onset CMV reactivation still remains a challenge. In this study, we...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Martyna Wlodarczyk, Agata Wieczorkiewicz-Kabut, Krzysztof Białas, Anna Koclęga, Izabela Noster, Patrycja Zielińska, Grzegorz Helbig
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Turkish Society of Hematology 2024-03-01
Serie:	Turkish Journal of Hematology
Soggetti:	allogeneic hematopoietic stem cell transplantation antiviral prophylaxis cytomegalovirus reactivation letermovir
Accesso online:	https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-82335&look4=
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!